<DOC>
	<DOCNO>NCT01833754</DOCNO>
	<brief_summary>This open-label , single-dose , parallel-group study conduct healthy subject subject stage 4 renal impairment ( RI ) end stage renal disease ( ESRD ) require hemodialysis evaluate safety , tolerability , immunogenicity profile romosozumab . Subjects enroll parallel 1 three treatment group receive single dose romosozumab .</brief_summary>
	<brief_title>Study Romosozumab ( AMG 785 ) Administered Healthy Subjects Subjects With Stage 4 Renal Impairment Stage 5 Renal Impairment Requiring Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>INCLUSION CRITERIA ALL SUBJECTS : Males female ≥ 50 year age Body weight ≥ 45 ≤ 110 kg Willing adhere calcium vitamin D supplementation requirement Females must nonreproductive potential INCLUSION CRITERIA SUBJECTS WITH RENAL IMPAIRMENT ( GROUPS 1 AND 2 ) : Group 1 Stage 4 RI ( estimate glomerular filtration rate ( eGFR ) 1529 mL/min/1.73 m2 ) Group 2 End stage renal disease require hemodialysis INCLUSION CRITERIA HEALTHY SUBJECTS ( GROUP 3 ) : • Renal function define estimate glomerular filtration rate ( eGFR ) ≥ 80 mL/min/1.73 m2 EXCLUSION CRITERIA ALL SUBJECTS : History metabolic bone disease ( except metabolic bone disease renal impairment ( RI ) subject ) History osteoporosis , vertebral fracture , fragility fracture wrist , humerus , hip , pelvis age 50 Recent bone fracture Vitamin D insufficiency Hypocalcemia hypercalcemia Hypomagnesemia Hypophosphatemia Untreated hyper hypothyroidism Females positive pregnancy test Males pregnant partner Females lactating/breastfeeding plan breastfeed study 3 month receive dose study drug History spinal stenosis History facial nerve paralysis Positive human immunodeficiency virus ( HIV ) antibodies Positive hepatitis B surface antigen detectable hepatitis C Malignancy ( except fully resect cutaneous basal cell squamous cell carcinoma , cervical , breast ductal carcinoma situ ) within 5 year screen History solid organ bone marrow transplant EXCLUSION CRITERIA HEALTHY SUBJECTS ( GROUP 3 ) Current hyper hypoparathyroidism</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Osteoporosis , Bone , Renal , Insufficiency , Kidney , Hemodialysis , Impairment</keyword>
</DOC>